Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis

AUTOR(ES)

Cavalcante, José Roosevelt, Sampaio, João Paulo Aguiar, Maia Filho, João Tarcísio Alves, Vieira, Renato Braga, Eleutério Júnior, José, Lima Júnior, Roberto César Pereira, Ribeiro, Ronaldo Albuquerque, Almeida, Paulo Roberto Carvalho

FONTE

Acta Cir. Bras.

DATA DE PUBLICAÇÃO

2014-10

RESUMO

PURPOSE: To investigate E-cadherin immunoexpression during cervical carcinogenesis. METHODS: We assessed the immunohistochemical expression of E-cadherin in squamous intraepithelial lesions (SIL - 52 cases), squamous cell carcinoma (SCC) of the uterine cervix (23 cases) and also in eight cases of cervicitis. RESULTS: The results show very different E-cadherin membrane expression levels when cervicitis (88%), SILs (73%) and SCC (17%) were compared. In SILs, higher E-cadherin loss was seen in less differentiated cells in the basal third of the epithelium. This study suggests that the absence of E-cadherin expression in the membrane is a molecular event that is observed more often in SCC of the uterine cervix than in SILs or cervicitis. CONCLUSIONS: E-cadherin is an essential molecule during the process of cervical carcinogenesis and in this context exhibits a different expression pattern according to the epithelial thickness layer.

Documentos Relacionados

• Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.
• E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
• E-cadherin expression in intestinal epithelium.
• Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis
• Loss of α-Catenin Decreases the Strength of Single E-cadherin Bonds between Human Cancer Cells*